# **Learning Outcomes (Slides 1â€“2)**

At the end you should be able to:

1. Identify **why ion channels matter**
    
2. Describe techniques to measure **current flow** through channels
    
3. Interpret **single-channel recordings**
    
4. Describe **mutations** that alter channel behaviour & cause pathology  
    

---

# ğŸ§  **2. Why Study Ion Channel Function? (Slides 3â€“5)**

Slide 4 shows Hodgkin & Huxley (Nobel 1963) â€” pioneers of ion channel electrophysiology.  
Slide 5: 2021 Nobel Prize â†’ **Julius & Patapoutian** for temperature & touch receptors (TRP channels, Piezo channels).  

**Key message:**  
Ion channels underlie:

- Action potentials
    
- Muscle contraction
    
- Cardiac rhythm
    
- Sensation (temperature, touch, pain)
    
- Hormone secretion
    

Mutations â†’ **channelopathies** (arrhythmias, epilepsy, MH, CPVT, periodic paralysis).

---

# âš¡ **3. Measuring Ion Channel Current (Slides 6â€“11)**

## **Ohmâ€™s Law (Slide 7)**

> V = I Ã— R

- V in mV
    
- I in pA
    
- R in MÎ©  
      
    Used to calculate **conductance** (g = 1/R).
    

---

## **A. Patch Clamp Technique (Slides 8â€“9)**

Nobel Prize 1991 â†’ Neher & Sakmann.

Slide 8 shows:

- A glass pipette forms a giga-seal with the cell membrane
    
- Allows **direct recording** of ionic currents through **single channels** or **whole cells**  
    

Modes include:

- **Voltage clamp** (fix V, measure I)
    
- **Current clamp** (fix I, measure V)
    

Slide 9 diagram:

- Ion channels â†’ amplifier â†’ digitiser â†’ computer
    
- Typical single-channel trace on right (square openings).  
    

---

## **B. Planar Lipid Bilayer Technique (Slides 10â€“11)**

Used for **intracellular** ion channels (e.g., RyR, TPC2).  
Slide 11 illustrates:

- Artificial bilayer separating **cis** & **trans** chambers
    
- Insert purified channel proteins
    
- Independent voltage control (Vp)
    
- Single-channel openings recorded as pA-level currents  
    

---

# ğŸ” **4. What We Can Learn From Single-Channel Recordings (Slides 12â€“20)**

---

## **4.1 What Opens a Channel? (Slide 13)**

Channels may be gated by:

- **Voltage** â†’ VG Naâº, VG Kâº channels
    
- **Ligand (external)** â†’ glutamate receptors
    
- **Ligand (internal second messenger)** â†’ RyR opened by CaÂ²âº
    
- **Stretch** â†’ mechanosensitive (Piezo)
    
- **Light** â†’ channelrhodopsin  
    

---

## **4.2 Channel Gating (Slides 14â€“15)**

Slide 14 shows real RyR2 single-channel trace:

- Upward deflections = openings
    
- Down = closed
    
- Stochastic behaviour (random open/close)
    

Slide 15 defines:

- **Open duration**
    
- **Closed duration**
    
- **Î”I** = amplitude of single-channel current
    
- **Po (open probability)** = t_open / t_total  
    

Po increases with agonists or depolarisation.

---

## **4.3 Kinetic Models of Gating (Slide 16)**

Diagram shows:  
A + R â‡Œ AR â‡Œ AR*

- **kon/koff** â†’ affinity
    
- **Î±/Î²** â†’ efficacy (opening/closing rates)  
    

These are state-transition models for ligand-gated channels.

---

## **4.4 Single-Channel Conductance (Slide 17)**

Conductance (g) = 1/R  
Measured from **single-channel current (I)** at different **voltages (V)** â†’ slope of Iâ€“V curve.

Slides show:

- Naâº channels: larger inward currents
    
- Kâº channels: outward currents  
    

---

## **4.5 Whole-Cell Current vs Single Channels (Slide 18)**

Equation on slide:  
**I = N Ã— Po Ã— i**  
Where:

- N = number of channels
    
- Po = open probability
    
- i = unitary current
    

Slide shows ensemble averages vs whole-cell current traces (Patlak & Ortiz 1985).  

---

## **4.6 Ion Selectivity (Slide 19)**

Use **Iâ€“V relationship** and **reversal potential (E_rev)**.

Slide example:

- Shift in E_rev with different Kâº concentrations â†’ consistent with **Nernst equation**
    

> E_ion = (RT/zF) ln([ion]_out/[ion]_in)  

Conclusion from slide: **Kâº ions are flowing through the channel**.

---

## **4.7 Channel Inhibitors (Slide 20)**

Classic selective blockers:

- **Tetrodotoxin (TTX)** â†’ blocks VG Naâº channels
    
- **Tetraethylammonium (TEA)** â†’ blocks VG Kâº channels  
    

---

# ğŸ”¥ **5. Ion Channels & Calcium Signalling (Slides 21â€“27)**

Slides 21â€“23 show the central importance of CaÂ²âº homeostasis.

---

## **5.1 CaÂ²âº Concentrations (Slide 21)**

- Cytosol: **~100 nM**
    
- ER/SR lumen: **~1 mM**
    
- Lysosomes: also high CaÂ²âº  
    

**CaÂ²âº is lifeâ€“death signalling**:

- Required for: fertilisation, secretion, heartbeat, contraction
    
- Excess CaÂ²âº â†’ apoptosis, ischemia, excitotoxicity, arrhythmias, **malignant hyperthermia**
    

Slide shows **TPC2** channels in lysosomes.

---

## **5.2 Cardiac Excitationâ€“Contraction Coupling (Slides 22â€“24)**

### **L-type CaÂ²âº channel (LTCC)** (on plasma membrane)

- AP arrives â†’ LTCC opens â†’ CaÂ²âº influx
    

### **RyR2 (Ryanodine Receptor 2)**

- CaÂ²âº influx triggers **calcium-induced calcium release (CICR)** from SR
    
- Produces contraction
    

### **SERCA**

- Pumps CaÂ²âº back into SR â†’ relaxation
    

Slide 23 shows RyR2 macromolecular complex:

- Bound to **FKBP12.6, calsequestrin, triadin, junctin**  
    

---

## **5.3 CPVT â€” Channelopathy of RyR2 (Slide 24)**

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT):

- Autosomal dominant
    
- Triggered by **stress/exercise**
    
- Symptoms: syncope, dizziness, **sudden death**
    
- > 69 mutations in **RyR2** identified  
    

Mechanism:

- Mutant RyR2 channels **leak CaÂ²âº** â†’ arrhythmias
    
- Especially during catecholaminergic stimulation (Î²-adrenergic â†‘ PKA phosphorylation)
    

---

## **5.4 Skeletal Muscle Excitationâ€“Contraction Coupling (Slides 25â€“27)**

### **LTCC (DHPR)** mechanically coupled to **RyR1**

Unlike the heart, skeletal muscle RyR1 activation is **mechanical**, not CaÂ²âº-induced.  

Process:

- AP â†’ LTCC conformational change
    
- Direct physical coupling â†’ RyR1 opens
    
- CaÂ²âº release â†’ contraction
    
- SERCA â†’ reuptake
    

---

## **5.5 Malignant Hyperthermia (Slide 27)**

Due to RyR1 mutations.  
Trigger: volatile anaesthetics or depolarising relaxants (succinylcholine).  
Symptoms intraoperatively:

- Muscle rigidity
    
- Hyperthermia
    
- Acidosis
    
- Tachycardia
    

Mechanism:

- RyR1 becomes **hyperactive** â†’ massive CaÂ²âº release â†’ metabolic crisis  
    

Treatment: **Dantrolene** (RyR inhibitor) â€” not listed on slides but well-known.

---

# ğŸ§  **6. Final Learning Outcomes Re-emphasised (Slide 28)**

Same as slide 2.  

---

# ğŸ”¥ğŸ”¥ **HIGH-YIELD EXAM SUMMARY (Ultra-Condensed)**

### **Techniques**

- **Patch clamp** â†’ cell-surface channels (single-channel + whole-cell)
    
- **Planar lipid bilayer** â†’ intracellular channels (e.g., RyR)
    

### **Single-Channel Analysis**

- Current amplitude (Î”I)
    
- Open probability Po = t_open / t_total
    
- Conductance g = I/V (from Iâ€“V curve)
    
- Ion selectivity â†’ **E_rev** vs Nernst equation
    

### **Key Blockers**

- **TTX** â†’ Naâº channels
    
- **TEA** â†’ Kâº channels
    

### **Cardiac CaÂ²âº signalling**

- LTCC â†’ CaÂ²âº in
    
- RyR2 â†’ CaÂ²âº release (CICR)
    
- SERCA â†’ relaxation
    
- RyR2 mutations â†’ **CPVT** (stress-induced VT)
    

### **Skeletal Muscle CaÂ²âº signalling**

- LTCC mechanically opens RyR1
    
- RyR1 mutations â†’ **Malignant Hyperthermia**
    

### **Channel Gating**

- Random opening/closing
    
- Kinetic model A + R â‡Œ AR â‡Œ AR*
    
- Affects Po and efficacy
    

### **Whole-Cell Current Equation**

**I = N Ã— Po Ã— i**